Understanding patient burden and unmet needs has always been essential in healthcare. But for rare diseases research, it is absolutely critical. When patient populations are small, heterogeneous, and often underserved, every insight carries weight. Yet traditional data sources—clinical trials, claims data, registries, and surveys—often fall short of capturing the lived reality of patients and caregivers…
As AI rapidly reshapes the evidence landscape, health technology assessment (HTA) bodies are beginning to define clear expectations for its use in submissions. At CapeStart, we work closely with life sciences clients navigating these changes—especially those integrating GenAI into literature reviews, RWE generation, economic modeling, Joint Clinical Assessment (JCA) support, Clinical Evaluation Reports (CERs), Patient…
In today’s fast-paced life sciences environment, literature reviews are critical—but they’re also time-consuming, labor-intensive, and increasingly expected to support regulatory, HEOR, and market access submissions while maintaining full transparency and traceability. While traditional platforms offer useful automation features, most are either rules-based classifiers or structured workflow tools, limiting their adaptability and explainability. That’s where MadeAi™…
